Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.


Company Details

Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071
Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071
Telephone: +64-6-390-6938
Facsimile: n/a
Website: www.ruabio.com
First Listed: 22/10/2020
Balance Date: 30 June
AGM: 12/10/2022

Directors and Executives

Trevor Burt
Independent Chairman
Panapa Ehau
Executive Director
Teresa Farac-Ciprian Independent Non-Executive Director
Brett Gamble
Non-Executive Director
Paul Naske
Chief Operating Officer
Anna Stove
Managing Director
Hamish White
Chief Financial Officer

Announcements


Major Holdings Announcements

Date Name No. Held % Current
18/03/22 Hikurangi Enterprises Limited 8,132,620 - 5.43
17/03/22 Hikurangi Bioactives Limited Partne 4,000,000 12.58 2.67
22/10/20 Fang Group Investment Limited and F 23,584,939 - 16.85
22/10/20 Tailorspace Capital Limited, Tailor 11,129,375 - 7.95
22/10/20 Andrew Charles Williams 7,756,838 - 5.54

Director’s Interests Announcements

Date Name No. Held % Details Other
02/11/21 Hamish White 320,154 - - -
02/11/21 Panapa Ehau 474,224 - - -
02/11/21 Rob Mitchell 288,251 - - -
02/11/21 Paul Naske 159,872 - - -
02/11/21 Trevor Burt 958,002 - - -
22/10/20 Martin Smith 2,544,732 - - -
22/10/20 Brett Gamble 1,805,914 - - -
22/10/20 Anna Stove 763,896 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 01/08/2022


Markets News

Pushpay investors ponder takeover as NZX50 marches on
Markets The close

Pushpay investors ponder takeover as NZX50 marches on

Yield stocks such as Chorus and property investors led the market higher. 

Matt Martel 13 Nov 2022
Markets

Paul McBeth: Building a property portfolio with Winton

Here's a way the Sharesies generation can get their fill of property.

Paul McBeth 03 Dec 2021
Building a property portfolio with Winton
Markets

Morningstar picks Spark as omicron refuge

Spark’s share price spiked more than 5% early this week as investors reacted to news of the variant, but it had been trending down, sliding more than 10% in the past three months.

Dan Brunskill 02 Dec 2021
Morningstar picks Spark as omicron refuge
Retail Free

It's happening – Ikea coming to Sylvia Park

Ikea is finally landing in New Zealand. Really.

Staff reporters 02 Dec 2021
It's happening – Ikea coming to Sylvia Park
Property

Winton delivers early Christmas present to NZX in $350m IPO

Macquarie will take a big piece of the action in Winton's Christmas initial public offering. 

Paul McBeth 01 Dec 2021
Winton delivers early Christmas present to NZX in $350m IPO